Cortex Pharm Aktie - COR

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Cortex Receives Delisting Notification from NYSE Amex

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) announced that it has received notification from the NYSE Amex LLC indicating that...

Cortex Reports Third Quarter Operating Results

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported a net loss applicable to common stock of $3,243,000, or $0.06 per share...

Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) President and CEO, Mark A. Varney, Ph.D., will present at Rodman & Renshaw’s...

Cortex Receives NYSE Amex Staff Determination

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported that it has received a delisting notification from the NYSE Amex LLC...

Cortex Reports Second Quarter Operating Results

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported a net loss applicable to common stock of $2,778,000, or $0.06 per share...

Cortex Pharmaceuticals Announces Financing

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported that it has entered into a definitive agreement with a single...

Cortex Annual Shareholder Meeting Notification

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR), a neuroscience company focused on developing novel AMPAKINE? drug therapies for...

Cortex Receives Notice of Non-Compliance from NYSE Amex for Continued Listing Requirements

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported that it has received notice from the NYSE Amex LLC indicating that the...

Cortex Reports First Quarter Operating Results

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported a net loss of $3,168,000, or $0.07 per share for the quarter ended March...

Cortex Announces Closing of Financing

Cortex Pharmaceuticals, Inc. (NYSE Amex:COR) announced that it has completed the previously announced sale of shares of a...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

COR - Frequently Asked Questions (FAQ)

What is the current Cortex Pharm share price?

The current share price of Cortex Pharm is US$ 0,00

What is the 1 year trading range for Cortex Pharm share price?

Cortex Pharm has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6,8555 (20,70%)	95,28M
TOONKartoon Studios Inc	US$ 0,6518 (17,76%)	762,97k
MSOXAdvisorShares MSOS Daily Leveraged ETF	US$ 5,42 (17,32%)	480,62k
NAKNorthern Dynasty Minerals Ltd	US$ 0,7254 (15,47%)	11,06M
YINNDirexion Daily FTSE China Bull 3X Shares	US$ 46,22 (15,09%)	9,54M
EXODExodus Movement Inc	US$ 28,997 (-31,74%)	170,54k
SGNSigning Day Sports Inc	US$ 0,780001 (-27,78%)	656,3k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 16,9824 (-20,86%)	30,77M
YANGDirexion Daily FTSE China Bear 3X Shares New	US$ 37,1302 (-15,03%)	7,53M
ATCHAtlasClear Holdings Inc	US$ 1,66 (-14,43%)	825,61k
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6,4499 (-3,15%)	107,11M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 21,9199 (6,15%)	99,97M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6,8555 (20,70%)	95,28M
FXIiShares China Large Cap	US$ 36,835 (5,12%)	64,15M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3,42 (-2,84%)	60,88M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Cortex Pharmaceuticals, (COR)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

COR Neueste Nachrichten

Cortex Receives Delisting Notification from NYSE Amex

Cortex Reports Third Quarter Operating Results

Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

Cortex Receives NYSE Amex Staff Determination

Cortex Reports Second Quarter Operating Results

Cortex Pharmaceuticals Announces Financing

Cortex Annual Shareholder Meeting Notification

Cortex Receives Notice of Non-Compliance from NYSE Amex for Continued Listing Requirements

Cortex Reports First Quarter Operating Results

Cortex Announces Closing of Financing

COR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Cortex Pharmaceuticals, (COR) Börsenkurse

Cortex Pharmaceuticals, (COR)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

COR Neueste Nachrichten

Cortex Receives Delisting Notification from NYSE Amex

Cortex Reports Third Quarter Operating Results

Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

Cortex Receives NYSE Amex Staff Determination

Cortex Reports Second Quarter Operating Results

Cortex Pharmaceuticals Announces Financing

Cortex Annual Shareholder Meeting Notification

Cortex Receives Notice of Non-Compliance from NYSE Amex for Continued Listing Requirements

Cortex Reports First Quarter Operating Results

Cortex Announces Closing of Financing

COR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE